Ascendis Pharma A/S

Healthcare · Biotechnology · Denmark

Last price 251.27 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 16.50B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing o...